Audience: Allergy and Immunology, Pediatrics
[Posted 06/04/2010]
ISSUE: Baxter BioScience and FDA notified healthcare professionals of a market withdrawal being conducted as a precautionary measure due to an increased number of adverse...
FDA Approves Baxter For New Immune System Drug
FDA Approves Baxter For New Immune System Drug
Baxter International (NYSE:BAX) announced Monday that a prescription drug for patients with dysfunctional immune systems has been approved for below-the-skin...
From:
FinancialNewsOnline
Views:
190
0
ratings
Time:
00:59
More in
News & Politics